LivaNova PLC (LIVN): Expected earnings per share growth for next year

Public company logo of LivaNova (LIVN)

LivaNova PLC (LIVN) relies on a high-tech combination of cardiac surgery and neuromodulation, creating barriers to changes in treatment standards. The GURU.Markets system highlights the earnings per share growth forecast trend, where the indicator has reached the level of 6.70. The integration of implants and monitoring makes the company's solutions a benchmark for saving lives, while stable demand for procedures guarantees a predictable cash flow.

LivaNova Corp (LIVN): Consensus forecast of earnings per share growth for next year from 07/04/2022 to 11/16/2026

Analytical breakdowns for LivaNova PLC

- price and consensus price forecast:
- stock exchange capitalization data:
Fundamental company analysis:LivaNova, LIVN
Core merchandise of livanova.com

High patent barriers and stringent FDA/EMA certification make LivaNova PLC revenues predictable, which directly impacts the calculation of expected earnings per share. This indicator aggregates daily expert estimate revisions, signaling a fundamental trend reversal through narrowing volatility in the projected EPS growth rate for next year, allowing investors to avoid missed opportunities when entering a trade.